Full Breakdown
FDA Moves to End GRAS Loophole with Mandatory Notification Rule
8/12/2026, 8:27:30 AM
Core Event
The U.S. Food and Drug Administration has issued a draft regulation requiring food and dietary-supplement manufacturers to notify the agency whenever they self-declare a new ingredient “generally recognized as safe” (GRAS). The rule replaces the voluntary notification system with a mandatory one, giving the FDA a public listing of such substances and a limited review window. The proposal was announced by Acting FDA Commissioner Kyle Diamantas and backed by Health Secretary Robert F. Kennedy Jr. as part of the administration’s effort to increase transparency in the food supply.
Background & Context
The GRAS pathway, created by the 1958 Food Additives Amendment, allowed companies to self-certify safety and optionally notify the FDA. Over decades the inventory grew to include thousands of synthetic and natural additives, many never reviewed by the agency. Critics call this a “secret GRAS loophole” that limits governmental visibility.
Data & Statistics
- More than 10,000 chemical substances are currently permitted in U.S. foods under GRAS.
- The draft rule sets a 45-day initial review after notification, followed by a 180-day substantive review in which the FDA may request additional data or reject the GRAS claim.
- A 120-day public comment window is open for stakeholder feedback.
Official Statements & Responses
Diamantas emphasized that the rule does not create a pre-market approval process; companies may continue to market ingredients while the agency reviews the notification. Kennedy argued the existing system leaves the FDA and the public without a complete picture of chemicals in the food supply and urged Congress to give the agency “additional tools” to keep pace with a changing food supply.
Industry groups warned that the new reporting requirements could overwhelm the FDA’s understaffed food-additive division and potentially expose manufacturers to litigation.
Criticism & Opposition
Advocacy groups say notification alone is insufficient. Melanie Benesh of the Environmental Working Group called the rule a “positive first step” but said “true GRAS reform requires more than mandatory notification.”
Food-and-drug attorney Todd Harrison warned that without congressional action, the FDA lacks authority to enforce meaningful change.
Conflicting Reports & Gaps
FDA officials note the additional disclosure burden could strain agency resources, especially after recent staff reductions. The draft rule does not specify enforcement mechanisms, leaving it unclear whether manufacturers will face penalties for non-notification. Inclusion in the public directory does not imply FDA endorsement of safety, according to former FDA food-program director Susan Mayne.
Verbatim Quotes
- “There is probably more interest now than ever at the congressional level,” — Kyle Diamantas
- “We should know what’s in our food. We should also know what’s in our food is safe,” — Melanie Benesh
- “Under the current system, the FDA does not even have a complete picture of what is entering the food supply, and neither does the American people,” — Robert F. Kennedy Jr.
What’s Next
The FDA will accept public comments for 120 days before finalizing the rule. Kennedy indicated the administration will petition Congress for legislation granting broader authority to review and, if necessary, restrict GRAS ingredients. Stakeholders—including industry groups, consumer-advocacy organizations, and congressional committees—are expected to weigh in during the comment period and subsequent legislative deliberations.
